A POSSIBLE PHARMACOLOGICAL APPROACH TO MIGRAINE
Authors:
- 1 August 1969
- journal article
- Published by Elsevier in The Lancet
- Vol. 294 (7615) , 298-300
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Mechanisms of the pressor and depressor actions of St 155 (2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride, catapres®)European Journal of Pharmacology, 1968
- Mechanism of Hypotensive Action of 2-(2,6-Dichlorophenylamino)-2-imidazoline Hydrochloride (ST-155) in the CatJournal of Pharmaceutical Sciences, 1968
- Cardiovascular effects of 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride (ST 115)European Journal of Pharmacology, 1968
- Experimental study on the circulatory effects of 2-(2,6-dichlorophenylamino)-2-imidazolinehydrochloride in manEuropean Journal of Clinical Pharmacology, 1968
- The antihypertensive effects of an imidazoline compoundClinical Pharmacology & Therapeutics, 1967
- CEREBRAL-CORTEX-PERFUSION RATES IN MIGRAINEThe Lancet, 1967
- Cerebral arteriography during migraine prodrome and headacheNeurology, 1964
- Biochemical Investigations in Headache: Increase in the Hydroxyindoleacetic Acid Excretion During Migraine AttacksInternational Archives of Allergy and Immunology, 1961
- Migraine Headache1960
- ANALYSIS OF CRANIAL ARTERY PULSE WAVES IN PATIENTS WITH VASCULAR HEADACHE OF THE MIGRAINE TYPEThe American Journal of the Medical Sciences, 1952